C07K 14/25
Shigella
Official title: Shigella (G)
C07K14/25 (Shigella) appears on 113 US grants and 157 published applications in this corpus.
Search patents in C07K- Granted patents
- 113
- Published applications
- 157
- Assignees
- 110
- Inventors
- 275
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 4 | 0 |
| 1999 | 4 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 4 | 4 |
| 2003 | 4 | 4 |
| 2004 | 3 | 5 |
| 2005 | 3 | 4 |
| 2006 | 4 | 6 |
| 2007 | 0 | 3 |
| 2008 | 2 | 3 |
| 2009 | 2 | 3 |
| 2010 | 3 | 9 |
| 2011 | 4 | 3 |
| 2012 | 4 | 2 |
| 2013 | 2 | 8 |
| 2014 | 9 | 4 |
| 2015 | 3 | 8 |
| 2016 | 3 | 11 |
| 2017 | 5 | 7 |
| 2018 | 3 | 8 |
| 2019 | 6 | 5 |
| 2020 | 3 | 5 |
| 2021 | 5 | 16 |
| 2022 | 10 | 13 |
| 2023 | 0 | 6 |
| 2024 | 6 | 11 |
| 2025 | 3 | 4 |
| 2026 | 2 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals26 May 2026US 12,637,495 B2Molecular Templates, Inc.
- Methods of producing Shiga toxin B-subunit (STxB) monomers and oligomers, and uses thereof20 Jan 2026US 12,527,854 B2Aphp (Assistance Publique - HôPitaux De Paris)
- Methods and compositions for use of recombinant bacterial effector proteins as anti-inflammatory agents2 Sep 2025US 12,404,307 B2Innate Biologics LLC
- Methods and compositions related to the next generation vaccine17 Jun 2025US 12,331,085 B2University of Kansas
- Optimized cell-free synthesis of invasion plasmid antigen B and related compositions and methods of use22 Apr 2025US 12,280,097 B2Vaxcyte, Inc.
- A broadly protective prophylactic vaccine against pseudomonas aeruginosa24 Sep 2026US 2026/0284172 A1University of Kansas
- Pentameric toxin protein-based target protein fusion pentamer producing platform using viral nucleocapsid2 Jul 2026US 2026/0184745 A1University-Industry Foundation, Yonsei University
- Shigella multiple antigen presenting immunogenic composition and fusion proteins thereof28 May 2026US 2026/0144857 A1Children's Medical Center Corporation
- Methods of producing shiga toxin b-subunit (stxb) monomers and oligomers, and uses thereof21 May 2026US 2026/0137765 A1Aphp (Assistance Publique - HôPitaux De Paris)
- Recombinant expression vector for melittin secretion and attenuated salmonella strain transformed therewith22 Jan 2026US 2026/0022390 A1The Industry & Academic Cooperation in Chungnam National University (IAC)
Most cited
By later US patents
- Hybrid molecules having translocation region and cell-binding region126US 5,668,255 ASeragen, Inc. · 1997
- Hybrid molecules having translocation region and cell-binding region85US 6,022,950 ASeragen, Inc. · 2000
- Recombinant DNAS encoding three-part hybrid proteins44US 5,965,406 ASeragen, Inc. · 1999
- Probe for DNA and a process for the detection of "shigellae" and entero-invasive strains of Escherichia coli31US 4,816,389 AInstitut National de la Sante et de la Recherche Medicale · 1989
- Compositions comprising a B subunit of Shiga toxin and a means stimulating NKT cells30US 8,685,408 B2Assistance Publique-Hopitaux de Paris · 2014